2 ‘secret’ growth stocks to watch right now

It’s time the secret was out about these outperforming stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Branded spirits and liqueurs company Stock Spirits Group (LSE: STCK) proved to be a great investment for shareholders during 2017. The shares rose around 56% to trade at today’s level close to 279p, but the firm still displays attractive metrics for quality, value and momentum, and I believe the stock warrants close attention now.

Today’s full-year results are encouraging. Constant currency revenue rose 3% during 2017 compared to the year before and adjusted basic earnings per share shot up more than 14%. In a sign that cash inflow backs profits, net debt closed down 11% for the year at just over €53m. The directors displayed their confidence in the outlook by pushing up the total dividend by almost 5%.

It’s all about brands

The firm offers a portfolio of products in Central and Eastern Europe that “are rooted in local and regional heritage.” Core operations cover Poland, the Czech Republic, Slovakia, Italy, Croatia and Bosnia & Herzegovina, but exports also go to more than 50 other countries around the world. Something is going right because sales volumes increased by 6.5% in 2017 and global sales volumes total more than 100m litres per year. 

When I think of Stock Spirits, I dream of it growing to become the next Diageo, and chief executive Mirek Stachowicz said in today’s report that after a strategic review the directors aim to focus more on its brands “to keep pace with the changing needs and tastes of our end consumers.” The idea is to “premiumise” the brands so that they become “more relevant to millennials.”  Planned tactics to achieve that include investing in digital marketing and adding new brands via carefully selected acquisitions.

A focus on brands is certainly what made Diageo mighty, but Stock Spirits may have a fair distance to travel if it is to expand its trading footprint further with its brands such as Stock, Fernet, Limonce, Zoedkowa, Saska, Keglevich and Zoedkowa. For now, the firm’s stated goal is to “become Central and Eastern Europe’s leading spirits business.”  Much of 2017’s share-price progress seemed to be driven by a recovery that the company engineered in its operations in Poland. With that recovery in place, I agree with Mr Stachowicz’s comment that Stock Spirits is now well positioned to achieve sustainable long-term growth.”

Simplification of operations

Meanwhile, full-year results from bio-decontamination and containment equipment manufacturer Bioquell (LSE: BQE) confirmed that the growth story remains on track for the firm. Since January 2017, the stock is up around 130%, driven by an impressive recovery in earnings.

During the year, the firm sold its airflow service business to concentrate on its core bio-decontamination operations, which now provide the majority of revenues. There is a residual business in the area of defence, but the directors expect the full benefits of an increased focus on bio-decontamination to show up in the results for profit during 2018.

I think that concentrating on a narrow area of operations is almost always a good thing and expect Bioquell to deliver growing profits in the years ahead. Executive Chairman Ian Johnson told us in today’s report that the company has invested in sales and marketing to “maximise” its potential in the international Life Sciences and Pharmaceutical market.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

In 3 steps, a new investor could start buying shares with just £500

Christopher Ruane outlines a trio of moves he thinks someone with a spare few hundred pounds could consider if they…

Read more »

Investing Articles

Up 513%! Can the Rolls-Royce share price  keep soaring in 2025?

Our writer sees reasons why the Rolls-Royce share price could go either way this year. Here's why he has no…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

£10,000 invested in Nvidia stock in 2020 would now be worth £244k! Here’s what could be next

Nvidia stock’s dominated the ‘picks and shovels’ market for artificial intelligence, but Dr James Fox believes it could be primed…

Read more »

Investing Articles

Next shares: the best FTSE 100 stock money can buy?

Next shares have performed brilliantly in recent years. Today's numbers suggest this momentum could continue into 2025, thinks Paul Summers.

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

£50k invested in NatWest shares one year ago would be worth this much today

NatWest shares soared in 2024 as interest rates remained high. Ken Hall considers if there is more cause for optimism…

Read more »

Investing Articles

ChatGPT thinks these are best UK shares to consider buying right now

Which five UK shares does ChatGPT think might be worthy of investment in 2025? Paul Summers reckons one pick might…

Read more »

Investing Articles

3 FTSE 100 stocks that could be takeover targets in 2025

Edward Sheldon believes these three FTSE businesses could be of interest to larger companies in their respective industries.

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Dividend Shares

Why is FTSE 100 stock Unilever tanking?

Since 9 September, FTSE 100 stock Unilever’s fallen more than 10%. Here, Edward Sheldon looks at what’s driving the share…

Read more »